Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Godavari DrugsBOM:530317 -0.49%54 Days Inventory is 165.68 as of Mar. 2026, which is 121% above its 10-year median of 74.89. GuruFocus rates BOM:530317 with a GF Score™ of 54/100 and a GF Value™ of ₹72.35 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 920 Drug Manufacturers companies, Godavari Drugs ranks worse than 53.7% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Godavari Drugs's Average Total Inventories for the
three
months ended in Mar. 2026 was ₹461 Mil. Godavari Drugs's Cost of Goods Sold for the
three
months ended in Mar. 2026 was ₹254 Mil.
Hence, Godavari Drugs's Days Inventory for the
three
months ended in Mar. 2026 was 165.68.
The historical rank and industry rank for Godavari Drugs's Days Inventory or its related term are showing as below:
BOM:530317'
s Days Inventory Range Over the Past 10 Years
Min: 34.53 Med: 74.89 Max: 174.28
Current: 173.08
During the past 13 years, Godavari Drugs's highest Days Inventory was 174.28. The lowest was 34.53. And the median was 74.89.
BOM:530317's Days Inventory is ranked worse than 53.7% of 920
companies
in the Drug Manufacturers industry
Industry Median: 165.11
vs BOM:530317: 173.08
Godavari Drugs's Days Inventory
increased
from Mar. 2025 (144.90) to Mar. 2026 (165.68).
It might indicate that Godavari Drugs's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Godavari Drugs's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.55.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Godavari Drugs's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.39.
Godavari Drugs (BOM:530317) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Godavari Drugs's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Godavari Drugs's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Godavari Drugs Days Inventory Related Terms
Godavari Drugs Days Inventory Historical Data
* Premium members only.
The historical data trend for Godavari Drugs's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Godavari Drugs's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Godavari Drugs Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Godavari Drugs's Days Inventory distribution charts can be found below:
* The bar in red indicates where Godavari Drugs's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Godavari Drugs (BOM:530317) has a Days Inventory of 165.68 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Godavari Drugs and its competitors. This is 121% above median its historical median of 74.89. Over the past decade, Godavari Drugs' Days Inventory has ranged from 34.53 to 174.28. According to the industry distribution chart, Godavari Drugs ranks #494 out of 920 companies in the Drug Manufacturers industry, placing it in the top 53.7%.
Is Godavari Drugs' Days Inventory too high?
Godavari Drugs' current Days Inventory of 165.68 is 121% above median its 10-year median of 74.89. Over the past 10 years, this metric has ranged from a low of 34.53 to a high of 174.28. The Drug Manufacturers industry median Days Inventory is 165.11. Godavari Drugs' value of 165.68 is 0.3% above this industry median. Based on the distribution chart, Godavari Drugs ranks #494 out of 920 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Godavari Drugs has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Godavari Drugs' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Godavari Drugs ranks #494 out of 920 companies for Days Inventory. This places Godavari Drugs in the lower half of its industry. The industry median Days Inventory is 165.11. Godavari Drugs' value of 165.68 is 0.3% above this benchmark. Historically, Godavari Drugs' own Days Inventory has ranged from 34.53 to 174.28 over the past decade. While the company's 10-year median is 74.89 vs. the industry median of 165.11, Godavari Drugs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.11, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Godavari Drugs's current Days Inventory of 165.68 is 0.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Godavari Drugs and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Godavari Drugs's current Days Inventory is 165.68, which is 121% above median its own 10-year median of 74.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Godavari Drugs stock overvalued right now?
Based on GuruFocus' analysis, Godavari Drugs (BOM:530317) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹72.35, compared to a current price of ₹102.50 — trading 41.7% above its estimated fair value. The current Days Inventory is 165.68, which is 121% above median its 10-year median of 74.89 and 0.3% above the Drug Manufacturers industry median of 165.11. Godavari Drugs' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Godavari Drugs (BOM:530317), the current Days Inventory is 165.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Godavari Drugs (BOM:530317) Overvalued in 2026?
Based on GuruFocus' analysis, Godavari Drugs stock appears to be overvalued.
The current stock price of ₹102.50 is trading 41.7% above its estimated GF Value™ of ₹72.35.
GuruFocus considers Godavari Drugs to be Significantly Overvalued.
Key valuation signals for BOM:530317:
Days Inventory: 165.68 (121% above median its 10-year median of 74.89)
GF Value™: ₹72.35 vs. price of ₹102.50 (41.7% above fair value)
Industry Position: 0.3% above the Drug Manufacturers median (#494 of 920)
No single metric tells the full story. See the BOM:530317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing of APl's, intermediates and fine chemicals,. The firm's product includes Ciprofloxacin hydrochloride, ciprofloxacin, ciprofloxacin lactate, ciprofloxacin lactate, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.
54GF Score
Get the complete analysis for BOM:530317
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530317 has been successfully added to your 
